Search results for: pediatric rheumatology

Ebola: Hemorrhagic Fever and Macrophage Activation Syndrome

W. Winn Chatham, MD, & Randy Q. Cron, MD, PhD | December 1, 2014

Rheumatologists focus on similar clinical, laboratory findings to better
understand pathobiology of Ebola infection

Cryopyrin-Associated Periodic Syndromes: Difficult to Recognize, Diagnose, Treat

Philip J. Hashkes, MD, MSc, & Ronald M. Laxer, MDCM, FRCPC | October 1, 2014

Two case studies demonstrate the difficulty, delay in recognizing this rare autoinflammatory disease

RheumPAC: The Voice of the ACR

Ed Herzig & the RheumPAC Committee | September 1, 2014

How the ACR’s political action committee represents interests of rheumatologists, patients with Congressional lawmakers

2013 ACR/ARHP Annual Meeting: Health Professionals In the Spotlight

Richard Quinn | January 1, 2014

ARHP members are honored with awards for research, education, advocacy, and patient care in rheumatology

Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life

Deborah M. Levy, MD, MS | January 1, 2014

Differences in disease manifestations, severity, and management require special consideration from rheumatologists who treat children and adolescents with systemic lupus erythematosus

2013 ACR/ARHP Annual Meeting: Rheumatologists In the Spotlight

Richard Quinn | December 1, 2013

ACR members honored with awards for service, research, and mentorship in rheumatology

ACR Issues sJIA Recommendations, SSc Classification Criteria

Kathy Holliman | October 1, 2013

Guidelines address advances in pathophysiology and treatment of systemic juvenile idiopathic arthritis; criteria classify broader spectrum of systemic sclerosis

What Adult Rheumatologists Need to Know about Juvenile Arthritis

Peter A. Nigrovic, MD | May 1, 2013

How to recognize distinctions between pediatric and adult arthritis

The ACR Releases Top 5 Things as Part of Choosing Wisely Campaign

Audrey B. Uknis, MD | February 21, 2013

On February 21, the ACR–along with 16 other national medical societies–released its list of Five Things Patients and Physicians Should Question in Rheumatology.

Aggressive Treatment of Inflammation Prevents Vision Loss in Patients with JIA-related Uveitis

Lara C. Pullen, PhD | January 24, 2013

A new study confirms that the use of immunosuppressive drugs is associated with a reduced risk of vision loss in patients with juvenile idiopathic arthritis-related uveitis.